Compagne, K. C. J. http://orcid.org/0000-0003-0608-835X
,
Boers, A. M. M.
Marquering, H. A.
Berkhemer, O. A.
Yoo, A. J.
Beenen, L. F. M.
van Oostenbrugge, R. J.
van Zwam, W.H.
Roos, Y. B. W. E. M.
Majoie, C. B.
van Es, A. C. G. M.
van der Lugt, A.
Dippel, D. W. J.
Lingsma, H.
Funding for this research was provided by:
Hartstichting
Angiocare B.V.
Medtronic/Covidien/EV3
MEDAC GmbH/LAMEPRO
Penumbra Inc
Stryker
Top Medical/Concentric
Bracco Imaging
Cerenovus
Neuravi Inc
Article History
Received: 16 March 2018
Revised: 21 May 2018
Accepted: 29 May 2018
First Online: 9 July 2018
Compliance with ethical standards
:
: The scientific guarantor of this publication is Kars C.J. Compagne.
: A. Boers and H. Marquering own stock in Nico-lab B.V. A. Yoo reports research grants form Penumbra Inc. and Neuravi Inc., and consultant fees from Cerenovus/J&J. No other personal disclosures are reported.
: H. Lingsma and K. Compagne performed statistical analysis for this study. One of the authors (H. Lingsma) has significant statistical expertise.
: Written informed consent was obtained from all subjects (patients) in this study.
: Institutional Review Board approval was obtained.
: Data were obtained from the MR CLEAN trial. Multiple studies have been performed with the data from the MR CLEAN trial. However, our data have not been reported in any other paper, sub-study or abstract.
: • prospective• randomised controlled trial• multicentre study